When did Alzamend Neuro, Inc. report Q1 2026 earnings?

Alzamend Neuro, Inc. (ALZN) reported Q1 2026 earnings on March 11, 2026 before market open.

What were Alzamend Neuro, Inc.'s Q1 2026 revenue and EPS?

Alzamend Neuro, Inc. reported diluted EPS of $-0.58 for Q1 2026.

EPS missed the consensus estimate of $-0.53 by $0.05.

Compared to the same quarter a year prior, diluted EPS grew 66.1% from $-1.71.

You can read the 10-Q periodic report (0001214659-26-003166) directly on SEC EDGAR. The filing index links above go to sec.gov.

Reported March 11, 2026 · Before market open

EPS estimate-$0.53

Jul 28, 2026 (in a month)

EPS estimate-$0.67

Q1 2026-$0.58Miss by $0.05

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

When did Alzamend Neuro, Inc. report Q1 2026 earnings?: Alzamend Neuro, Inc. (ALZN) reported Q1 2026 earnings on March 11, 2026 before market open.
What were Alzamend Neuro, Inc.'s Q1 2026 revenue and EPS?: Alzamend Neuro, Inc. reported diluted EPS of $-0.58 for Q1 2026.
Did Alzamend Neuro, Inc. beat estimates in Q1 2026?: EPS missed the consensus estimate of $-0.53 by $0.05.
How did Alzamend Neuro, Inc.'s Q1 2026 results compare year-over-year?: Compared to the same quarter a year prior, diluted EPS grew 66.1% from $-1.71.
Where can I find Alzamend Neuro, Inc.'s Q1 2026 SEC filings?: You can read the 10-Q periodic report (0001214659-26-003166) directly on SEC EDGAR. The filing index links above go to sec.gov.